MENU

SABS SAB Biotherapeutics Forecast, Technical & Fundamental Analysis

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders... Show more

SABS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
SABS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SABS is expected to report earnings to fall 2.75% to -27 cents per share on November 17

SAB Biotherapeutics SABS Stock Earnings Reports
Q3'26
Est.
$-0.27
Q2'26
Missed
by $0.01
Q1'26
Beat
by $0.23
Q4'25
Missed
by $0.13
Q3'25
Missed
by $0.09
The last earnings report on August 06 showed earnings per share of -28 cents, missing the estimate of -26 cents. With 87.94K shares outstanding, the current market capitalization sits at 292.52M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
777 West 41st Street
Phone
+1 305 845-2813
Employees
86
Web
https://www.sab.bio
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SYLD81.120.53
+0.66%
Cambria Shareholder Yield ETF (SYLD)
AESR19.970.09
+0.45%
Anfield U.S. Equity Sector Rotation ETF (AESR)
SPYG123.390.31
+0.25%
State Street SPDR Portfolio S&P 500 Growth ETF (SPYG)
MMAX27.49N/A
+0.01%
iShares Large Cap Max Buffer Mar ETF (MMAX)
NBCE37.02-0.19
-0.50%
Neuberger China Equity ETF (NBCE)

SABS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-3.47%
REVB - SABS
48%
Loosely correlated
-1.96%
INKT - SABS
47%
Loosely correlated
+1.43%
CYPH - SABS
46%
Loosely correlated
-12.31%
TECX - SABS
35%
Loosely correlated
-2.66%
RANI - SABS
34%
Loosely correlated
+0.57%
More
SAB Biotherapeutics (SABS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com